Skip to main content
SONOSCAPE MEDICAL CORP. logo

SONOSCAPE MEDICAL CORP. — Investor Relations & Filings

Ticker · 300633 ISIN · CNE100002P91 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,204 across all filing types
Latest filing 2026-03-20 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 300633

About SONOSCAPE MEDICAL CORP.

https://www.sonoscape.com

SonoScape Medical Corp. specializes in the research, development, and manufacturing of advanced medical diagnostic equipment. The company's primary product portfolio includes high-definition ultrasound systems, flexible endoscopy solutions, and electrocardiography devices. SonoScape focuses on delivering innovative imaging technology to healthcare providers globally, ranging from portable diagnostic tools to comprehensive trolley-based systems. Their ultrasound range covers various clinical applications such as cardiology, obstetrics, and radiology, while their endoscopy division provides high-resolution video processors and scopes for gastrointestinal and respiratory procedures. The company emphasizes continuous technological advancement and clinical efficiency to improve patient outcomes and diagnostic accuracy in diverse medical settings.

Recent filings

Filing Released Lang Actions
关于回购股份事项前十名股东及前十名无限售条件股东持股情况的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from Shenzhen Kaili Biomedical Technology Co., Ltd. regarding the shareholding situation of the top ten shareholders and top ten unrestricted shareholders prior to a share repurchase plan. It references a board meeting approving a share repurchase plan and provides detailed shareholding data. The content focuses on shareholding details related to a share buyback, not on financial results, management changes, or legal matters. It is not a full financial report or earnings release, nor is it a regulatory certification or voting result. The document fits the category of a Transaction in Own Shares (POS) as it relates to the company's share repurchase activities and shareholder holdings relevant to that transaction.
2026-03-20 Chinese
关于召开2026年第一次临时股东会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2026 first extraordinary general meeting (临时股东会) of Shenzhen Kaili Biomedical Technology Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items (notably a share repurchase proposal), registration details, and attachments such as proxy forms and voting instructions. The document is a formal announcement to shareholders about the meeting and how to participate and vote on specific proposals. It does not contain financial statements, audit opinions, or management discussions of financial results. It is not a report or transcript but a meeting notice and procedural guide. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings, including notices of meetings and related materials.
2026-03-17 Chinese
第四届董事会第十四次会议决议公告
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 14th meeting of the 4th Board of Directors of Shenzhen Kaili Biomedical Technology Co., Ltd. It details the approval of a share repurchase plan, including purpose, conditions, price range, funding sources, implementation period, and authorization for execution. The document is a board meeting resolution announcement rather than a full report or financial statement. It does not contain financial statements or detailed financial analysis but focuses on corporate governance decisions related to share buybacks. Therefore, it fits best under the category of Transaction in Own Shares (POS), which covers announcements of company share repurchase activities.
2026-03-17 Chinese
关于回购公司股份方案的公告
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement from Shenzhen Kaili Biomedical Technology Co., Ltd. regarding a share repurchase plan. It includes specifics about the purpose, price range, amount, funding source, implementation period, and risks associated with the share buyback. The document also discusses the impact on the company's capital structure and includes board resolutions and shareholder meeting requirements. The content is focused on the company's plan to repurchase its own shares and the related procedural and regulatory details. This matches the definition of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back or selling its own shares. The document is not a financial report, earnings release, or regulatory announcement but a formal share repurchase plan disclosure.
2026-03-17 Chinese
关于选举职工代表董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of an employee representative director to the company's board. It details the election process, the qualifications of the elected director, and compliance with relevant laws and company bylaws. There is no financial data, no report or presentation, and no mention of voting results from a general meeting. The document is a formal announcement about a change in board composition, specifically the election of a board member representing employees. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on this specific management change, confirming the classification.
2025-12-30 Chinese
北京市中伦（深圳）律师事务所关于公司2025年第二次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, notification, attendance, voting procedures, and results of the 2025 second extraordinary general meeting (临时股东大会) of Shenzhen Kaili Biomedical Technology Co., Ltd. It details the legality and validity of the meeting procedures and voting outcomes. The document does not contain financial statements or financial performance data, nor is it a report of financial results or management discussion. It is a legal opinion related to shareholder meeting procedures and voting results. This type of document is best classified as a Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholders' meeting and confirms the validity of the process.
2025-12-30 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.